Clinical Trials Browser

Neoplasms × cabozantinib × 30 days × Clear all

NCT05660954 2026-04-02

CABOTHYROID

Phase 2 Active not recruiting

Neoplasms, Thyroid Diseases

NCT03899155 2026-04-01

Pan Tumor Rollover Study

Phase 2 Recruiting

Neoplasms